GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Revance Therapeutics Inc (STU:RTI) » Definitions » Other Gross PPE

Revance Therapeutics (STU:RTI) Other Gross PPE : €69.4 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Revance Therapeutics Other Gross PPE?

Revance Therapeutics's Other Gross PPE for the quarter that ended in Sep. 2024 was €69.4 Mil.

Revance Therapeutics's quarterly Other Gross PPE increased from Mar. 2024 (€80.7 Mil) to Jun. 2024 (€86.0 Mil) but then declined from Jun. 2024 (€86.0 Mil) to Sep. 2024 (€69.4 Mil).

Revance Therapeutics's annual Other Gross PPE declined from Dec. 2021 (€45.9 Mil) to Dec. 2022 (€15.5 Mil) but then increased from Dec. 2022 (€15.5 Mil) to Dec. 2023 (€82.7 Mil).


Revance Therapeutics Other Gross PPE Historical Data

The historical data trend for Revance Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revance Therapeutics Other Gross PPE Chart

Revance Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.72 29.27 45.86 15.47 82.72

Revance Therapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.20 82.72 80.73 86.04 69.37

Revance Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Revance Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1222 Demonbreun Street, Suite 2000, Nashville, TN, USA, 37203
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

Revance Therapeutics Headlines

No Headlines